The Phoenix Mills Ltd. (PDF)
Top Losers
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
Adani Ports and SEZ
Ipca Laboratories Ltd. Share Price
Pharmaceuticals & DrugsIpca Laboratories Ltd. (INR)1361.82.7 (0.2%) 
Exchange ScripsBSE524494NSEIPCALABISININE571A01038
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Ipca Laboratories Ltd. Performance
Market performance
Open price1366.5
High1374.6
Volumes231621
Prev Close1361.8
Low1348.1
Closing date2025-06-18
Historical performance
1 Year High1755.90
3 Year High1755.90
5 Year High1755.90
1 Year Low1052.00
3 Year Low669.80
5 Year Low669.80
Ipca Laboratories Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
NaN
Face Value (₹)
P/E Ratio
Dividend Yield
N/A
Ipca Laboratories Ltd. Investment Returns
1 Year
17.1%
3 Years
57.2%
5 Years
70.3%
10 Years
301.9%
Ipca Laboratories Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1366.96 | Bearish |
| 10-DMA | 1372.13 | Bearish |
| 20-DMA | 1407.54 | Bearish |
| 50-DMA | 1400.19 | Bearish |
| 100-DMA | 1412.81 | Bearish |
| 200-DMA | 1482.17 | Bearish |
Shareholding Pattern
| Field | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
| Promoters | 16 | 16 | 16 | 16 | 16 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 16 | 16 | 16 | 16 | 16 |
| Public Investors | 88290 | 90173 | 82959 | 84737 | 81149 |
| Government | --- | --- | --- | --- | --- |
Ipca Laboratories Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 1844 | 1518 | 1217 | 1292 |
| Operating Profit | 14484 | 10550 | 13793 | 16104 |
| Interest | 1408 | 482 | 112 | 123 |
| Depreciation | 3572 | 2616 | 2324 | 2092 |
| Profit Before Tax | 8427 | 7453 | 11357 | 13890 |
| Consolidated Net Profit | 5473 | 4713 | 8841 | 11400 |
| Adjusted EPS | 22 | 19 | 35 | 45 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 254 | 254 | 254 | 254 |
| Total Reserves | 63052 | 58166 | 54395 | 46763 |
| Minority Interest | 13948 | 733 | 769 | 145 |
| Total Non-Current Liabilities | 10144 | 9017 | 6139 | 1897 |
| Total Liabilities | 110970 | 86229 | 76215 | 60664 |
| Capital Work in Progress | 3236 | 1222 | 2939 | 1837 |
| Total Assets | 110970 | 86229 | 76215 | 60664 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 9447 | 8058 | 8561 | 10901 |
| Cash Flow from Investing Activities | -12918 | -7250 | -8550 | -5207 |
| Cash Flow from Financing Activitie | -5525 | 5072 | 4268 | -3058 |
| Net Cash Inflow / Outflow | -8997 | 5880 | 4278 | 2636 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 63.12.
- 3Y Stock Price CAGR of the stock is 15.8.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹14484 Million.
- The company generated revenue of ₹76624 Million in the previous financial year.
Ipca Laboratories Ltd.
1361.82.7 (0.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1201517.6
No. of Shares: 882.3
Performance:20.2%
P/L: ₹201517.6
Top Gainers
| Symbol | Change% |
|---|---|
| EMIL | 158.37(18%) |
| SILLYMONKS | 18(14%) |
| OPTIEMUS | 684.6(11%) |
| AAKASH | 9.7(11%) |
| PFOCUS | 130.98(10%) |
Similar stocks
Announcing Stock of the Month!
Live video call With Our Agent